• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NCCN 指南®洞察:鳞状细胞皮肤癌,版本 1.2022。

NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.

机构信息

Dana-Farber/Brigham and Women's Cancer Center.

Duke Cancer Institute.

出版信息

J Natl Compr Canc Netw. 2021 Dec;19(12):1382-1394. doi: 10.6004/jnccn.2021.0059.

DOI:10.6004/jnccn.2021.0059
PMID:34902824
Abstract

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.

摘要

NCCN 鳞状细胞皮肤癌指南为患有皮肤鳞状细胞癌的患者提供了诊断评估、临床分期和治疗选择的建议。NCCN 专家组每年开会讨论根据专家组成员和机构审查的意见以及 NCCN 内部和外部组织提交的内容对指南进行的更新。这些 NCCN 指南见解重点介绍了新的手术推荐术语(周边和深层全面切缘评估),以及近期在局部预防、局部和转移性疾病的免疫治疗以及放射治疗方面的更新。

相似文献

1
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.NCCN 指南®洞察:鳞状细胞皮肤癌,版本 1.2022。
J Natl Compr Canc Netw. 2021 Dec;19(12):1382-1394. doi: 10.6004/jnccn.2021.0059.
2
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.NCCN 指南®洞察: Merkel 细胞癌,第 1.2024 版。
J Natl Compr Canc Netw. 2024 Jan;22(1D):e240002. doi: 10.6004/jnccn.2024.0002.
3
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.NCCN 指南®洞察:黑色素瘤:皮肤,第 2.2024 版。
J Natl Compr Canc Netw. 2024 Jul;22(5):290-298. doi: 10.6004/jnccn.2024.0036.
4
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.肛门癌临床实践指南(2012 年版):NCCN 指南的重点更新内容。
J Natl Compr Canc Netw. 2012 Apr;10(4):449-54. doi: 10.6004/jnccn.2012.0046.
5
Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management.将基因表达谱分析纳入 NCCN 高风险皮肤鳞状细胞癌管理建议:对患者管理的影响。
Curr Med Res Opin. 2020 Aug;36(8):1301-1307. doi: 10.1080/03007995.2020.1763284. Epub 2020 May 18.
6
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.NCCN 指南®洞察:前列腺癌,第 1.2023 版。
J Natl Compr Canc Netw. 2022 Dec;20(12):1288-1298. doi: 10.6004/jnccn.2022.0063.
7
Adherence to the National Comprehensive Cancer Network Criteria of Complete Circumferential Peripheral and Deep Margin Assessment in Treatment of High-Risk Basal and Squamous Cell Carcinoma.遵循国家综合癌症网络标准,评估高危基底细胞和鳞状细胞癌的完全环周和深层切缘。
Dermatol Surg. 2020 Dec;46(12):1473-1480. doi: 10.1097/DSS.0000000000002354.
8
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.转移性结直肠癌临床实践指南(2013 年第 3 版):NCCN 指南的重点更新内容。
J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152. doi: 10.6004/jnccn.2013.0022.
9
Melanoma, version 2.2013: featured updates to the NCCN guidelines.黑色素瘤,2.2013 年版:NCCN 指南的特色更新。
J Natl Compr Canc Netw. 2013 Apr 1;11(4):395-407. doi: 10.6004/jnccn.2013.0055.
10
Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology.皮肤鳞状细胞癌高危特征综述以及美国癌症联合委员会与美国国立综合癌症网络肿瘤学临床实践指南之间的差异
Head Neck. 2017 Mar;39(3):578-594. doi: 10.1002/hed.24580. Epub 2016 Nov 24.

引用本文的文献

1
Letter to the editor regarding "Risk factors for incomplete excision of cutaneous squamous cell carcinoma: A single-center study performed on 1082 excisions in Northern Italy".致编辑的信:关于“皮肤鳞状细胞癌切除不完全的危险因素:在意大利北部对1082例切除术进行的单中心研究”
JPRAS Open. 2025 Aug 7;45:471-472. doi: 10.1016/j.jpra.2025.08.010. eCollection 2025 Sep.
2
Review of Applications of Zeolites in Dermatology: Molecular Perspectives and Translational Potentials.沸石在皮肤病学中的应用综述:分子视角与转化潜力
Int J Mol Sci. 2025 Jul 16;26(14):6821. doi: 10.3390/ijms26146821.
3
Microsurgical Reconstruction with Free Tissue Transfer in Skin Cancer Patients: A Systematic Review.
皮肤癌患者游离组织移植的显微外科重建:一项系统综述。
Cancers (Basel). 2025 Jul 17;17(14):2371. doi: 10.3390/cancers17142371.
4
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalation.皮肤鳞状细胞癌患者选择性停用PD-1抑制剂后的临床结局:探索治疗降阶梯策略
Cancer Immunol Immunother. 2025 Jul 5;74(8):260. doi: 10.1007/s00262-025-04115-y.
5
Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma.可解释的联邦深度学习模型预测皮肤鳞状细胞癌的疾病进展风险。
NPJ Precis Oncol. 2025 Jun 28;9(1):205. doi: 10.1038/s41698-025-00997-4.
6
Imaging and sentinel lymph node biopsy in high risk head and neck cutaneous squamous cell carcinoma: a Chinese cohort study.高危头颈部皮肤鳞状细胞癌的影像学检查与前哨淋巴结活检:一项中国队列研究。
Front Oncol. 2025 Jun 12;15:1507137. doi: 10.3389/fonc.2025.1507137. eCollection 2025.
7
Retrieval Augmented Generation-Enabled Large Language Model for Risk Stratification of Cutaneous Squamous Cell Carcinoma.用于皮肤鳞状细胞癌风险分层的基于检索增强生成的大语言模型
JAMA Dermatol. 2025 Jun 11. doi: 10.1001/jamadermatol.2025.1614.
8
From neglect to necessity: the role of innate immunity in cutaneous squamous cell carcinoma therapy.从被忽视到成为必需:先天性免疫在皮肤鳞状细胞癌治疗中的作用
Front Immunol. 2025 Apr 25;16:1570032. doi: 10.3389/fimmu.2025.1570032. eCollection 2025.
9
Perspective on the use of fluorescence molecular imaging for peripheral and deep margin assessment.外周和深部切缘评估中荧光分子成像的应用前景
J Biomed Opt. 2025 Jan;30(Suppl 1):S13711. doi: 10.1117/1.JBO.30.S1.S13711. Epub 2025 May 2.
10
Exposed Necrotic Bone in a Head and Neck Cancer Patient: Report of a Diagnostic Challenge.一名头颈癌患者出现暴露的坏死骨:诊断难题报告。
Diagnostics (Basel). 2025 Apr 9;15(8):952. doi: 10.3390/diagnostics15080952.